mRNA-based modalities for infectious disease management

The novel coronavirus disease 2019 (COVID-19) is still rampant all over the world, causing incalculable losses to the world. Major pharmaceutical organizations around the globe are focusing on vaccine research and drug development to prevent further damage caused by the pandemic. The messenger RNA (...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Mengjie, Hussain, Abid, Yang, Haiyin, Zhang, Jinchao, Liang, Xing-Jie, Huang, Yuanyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tsinghua University Press 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258466/
https://www.ncbi.nlm.nih.gov/pubmed/35818566
http://dx.doi.org/10.1007/s12274-022-4627-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258466/
https://www.ncbi.nlm.nih.gov/pubmed/35818566
http://dx.doi.org/10.1007/s12274-022-4627-5

Ejemplares similares